BIT

5.00%

1.9¢ biotron limited

sorry if already posted !personally believe we are major...

First 216 Last

Share
Profile

Follow
CatmanRules

2,096 Posts.

607

07/04/24

13:21

Post #: 73226458
Share

Originally posted by Batmansdaughter: ↑

Just a quicky after reading some above, particularly Nails&glue's analysis

without seeing the full data set, I'm confident by these headline results shown thus far because there easiest interpretation state that the trial has achieved its purpose. They can't say that and later release data that does not support it, and unfortunately I don't have a conspiratorial bone in my body, and if I did, I'd rip it out!

It is not possible to provide detailed analysis without the full data set. Comments above stating that the results seem to be no different from previous trial are premature. Most importantly though, it is the analysis of the full results in light of 6 more years of learning that has to be considered. HIV is a ocmplex disease and many unknowns still remain, and even though the latest ART has improved, any new progress will be well recieved.

The importance of rapid reduction in plasma viral load is critical because it enables higher levels of CD4 T cells to maintained. These cells are the primary immunity response cells, but many other cells involed in the equation and are too numerous to mention now. Keep in mind though that CD4 cell counts are a principle measure of disease progression.

They are actually prone to be latched upon by HIV cells prior to penetration and replication, utilizing its Vpu viroporin, just as SARS2 uses its own E viroporin to penetrate. Then viral assemby rapidly occurs leaving to CD4 cell death rapid generation of new virus, resulting in a weakened immunity from the twofold effect of having less CD4 cells and more virus that goes on to further replicate. Hence the need for rapid intervention.

The cytokine storm that we became familiar with C19 also plays a part here.

Any drug that reduces viral load quicker will most likely be well received, especially if it has a new mode of action and with immuntherapy benefits. The oustanding data analysis will shed light on how the immune system benefits, which was lacking in the previous trial.

Nothing wrong now.

Expand

sorry if already posted !

personally believe we are major DERISKED now ---

Bring on next news - EXCITING TIMES

BIT Price at posting: 8.2¢ Sentiment: Buy Disclosure: Held
22 Upvote

3 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 82 more messages in this thread...

First 216 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 1.9¢		Change -0.001(5.00%)		Mkt cap ! $17.14M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$5.671K	298.4K

Buyers (Bids)

No.	Vol.	Price($)
3	512798	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	1050263	5

View Market Depth

No.	Vol.	Price($)
3	512798	0.019
10	1774771	0.018
8	927388	0.017
12	3258350	0.016
7	865000	0.015

Price($)	Vol.	No.
0.020	1000263	4
0.021	555000	2
0.022	997769	4
0.023	1100772	2
0.024	153949	2

Last trade - 15.59pm 04/10/2024 (20 minute delay)

BIT (ASX) Chart

sorry if already posted !personally believe we are major...

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

sorry if already posted !personally believe we are major...

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News